Stay updated on SB8 vs Avastin in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the SB8 vs Avastin in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SB8 vs Avastin in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:17:56.000Z thumbnail image
  4. Check
    30 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:39:21.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T06:17:16.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T21:35:07.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:16:18.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The latest update includes the posting of results on the best overall response rate (ORR) by 24 weeks, detailing the definitions of complete and partial responses, as well as the incidence of treatment-related adverse events and anti-drug antibodies, while previous entries regarding ORR by 24 weeks and related metrics have been removed.
    Difference
    29%
    Check dated 2024-12-21T23:45:05.000Z thumbnail image

Stay in the know with updates to SB8 vs Avastin in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SB8 vs Avastin in Lung Cancer Clinical Trial page.